My Treatment Approach: Androgen Receptor Inhibitors and the Evolving Treatment Paradigm in Castration-Sensitive Prostate Cancer - Episode 6

Patient Case 1: Non-Metastatic CSPC with Rapidly Doubling PSA

,

Experts present a case study of a patient with non-metastatic castration-sensitive prostate cancer exhibiting rapid PSA doubling, highlighting the clinical implications and potential treatment considerations.

  1. Efstathiou: What are your impressions of the patient case? How would you evaluate and risk stratify this patient?